Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela George

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Gland Surgery|July 13, 2018
Nipple-sparing mastectomy in women at high risk of developing breast cancerRebecca S Lewis, Angela George, Jennifer E Rusby
Expert Opinion on Pharmacotherapy|September 22, 2017
The role of Cediranib in ovarian cancerCecilia Orbegoso, Gloria Marquina, Angela George, et al.
Journal of Medical Genetics|September 13, 2019
Germline <i>BRCA1</i> and <i>BRCA2</i> testing for breast cancer survivorsJennifer Wiggins, Anne McLoughlin, Angela George, et al.
Breast (Edinburgh, Scotland)|December 28, 2022
Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Quratul Ain, Caroline Richardson, Miriam Mutebi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerAnthony Eccleston, Anthony Bentley, Matthew Dyer, et al.
Journal of Community Genetics|February 29, 2016
A cost analysis of a cancer genetic service model in the UKIngrid Slade, Helen Hanson, Angela George, et al.
Scientific Reports|February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their managementMegan Rumford, Mark Lythgoe, Iain McNeish, et al.
British Journal of Nursing (Mark Allen Publishing)|June 28, 2016
The integration of BRCA testing into oncology clinicsNatalie Percival, Angela George, Jennifer Gyertson, et al.
Clinical Medicine (London, England)|July 17, 2019
Genomics: the power, potential and pitfalls of the new technologies and how they are transforming healthcareKatherine S Josephs, Alison Berner, Angela George, et al.
BMC Cancer|July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleAngela George, Jennifer McLachlan, Nina Tunariu, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Gland Surgery|July 13, 2018
Nipple-sparing mastectomy in women at high risk of developing breast cancerRebecca S Lewis, Angela George, Jennifer E Rusby
Expert Opinion on Pharmacotherapy|September 22, 2017
The role of Cediranib in ovarian cancerCecilia Orbegoso, Gloria Marquina, Angela George, et al.
Journal of Medical Genetics|September 13, 2019
Germline <i>BRCA1</i> and <i>BRCA2</i> testing for breast cancer survivorsJennifer Wiggins, Anne McLoughlin, Angela George, et al.
Breast (Edinburgh, Scotland)|December 28, 2022
Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Quratul Ain, Caroline Richardson, Miriam Mutebi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerAnthony Eccleston, Anthony Bentley, Matthew Dyer, et al.
Journal of Community Genetics|February 29, 2016
A cost analysis of a cancer genetic service model in the UKIngrid Slade, Helen Hanson, Angela George, et al.
Scientific Reports|February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their managementMegan Rumford, Mark Lythgoe, Iain McNeish, et al.
British Journal of Nursing (Mark Allen Publishing)|June 28, 2016
The integration of BRCA testing into oncology clinicsNatalie Percival, Angela George, Jennifer Gyertson, et al.
Clinical Medicine (London, England)|July 17, 2019
Genomics: the power, potential and pitfalls of the new technologies and how they are transforming healthcareKatherine S Josephs, Alison Berner, Angela George, et al.
BMC Cancer|July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleAngela George, Jennifer McLachlan, Nina Tunariu, et al.
Pageof 5